Loading
PDBj
メニューPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

3HRB

p38 kinase Crystal structure in complex with small molecule inhibitor

3HRB の概要
エントリーDOI10.2210/pdb3hrb/pdb
分子名称Mitogen-activated protein kinase 14, [3-amino-2-(2-methylphenyl)-1-oxidopyridin-4-yl](2,4-difluorophenyl)methanone (3 entities in total)
機能のキーワードp38 map kinase, transferase, inhibitor complex, alternative splicing, atp-binding, cytoplasm, kinase, nucleotide-binding, nucleus, phosphoprotein, polymorphism, serine/threonine-protein kinase
由来する生物種Homo sapiens (human)
細胞内の位置Cytoplasm (By similarity): Q16539
タンパク質・核酸の鎖数1
化学式量合計41552.32
構造登録者
Segarra, V.,Lumeras, W.,Vidal, B.,Leonard, P.,Fisher, M.,Lamers, M. (登録日: 2009-06-09, 公開日: 2009-09-01, 最終更新日: 2023-11-01)
主引用文献Lumeras, W.,Caturla, F.,Vidal, L.,Esteve, C.,Balague, C.,Orellana, A.,Dominguez, M.,Roca, R.,Huerta, J.M.,Godessart, N.,Vidal, B.
Design, synthesis, and structure-activity relationships of aminopyridine N-oxides, a novel scaffold for the potent and selective inhibition of p38 mitogen activated protein kinase
J.Med.Chem., 52:5531-5545, 2009
Cited by
PubMed Abstract: A novel series of aminopyridine N-oxides were designed, synthesized, and tested for their ability to inhibit p38alpha MAP kinase. Some of these compounds showed a significant reduction in the LPS-induced TNFalpha production in human whole blood. Structure-activity relationship studies revealed that N-oxide oxygen was essential for activity and was probably a determinant factor for a marked selectivity against other related kinases. Compound 45 was identified as a potent and selective p38alpha inhibitor with an appropriate balance between potency and pharmacokinetics. In vivo efficacy of 45 was demonstrated in reducing TNFalpha levels in an acute murine model of inflammation (ED(50) = 1 mg/kg in LPS-induced TNFalpha production when dosed orally 1.5 h prior to LPS administration). The oral efficacy of 45 was further demonstrated in a chronic model of adjuvant arthritis in rats with established disease when administered orally (ED(50) = 4.5 mg/kg).
PubMed: 19678708
DOI: 10.1021/jm9008604
主引用文献が同じPDBエントリー
実験手法
X-RAY DIFFRACTION (2.2 Å)
構造検証レポート
Validation report summary of 3hrb
検証レポート(詳細版)ダウンロードをダウンロード

246905

件を2025-12-31に公開中

PDB statisticsPDBj update infoContact PDBjnumon